Table 3. Salivary levels of NF-κB mediators in leukoplakia, lichen, submucous fibrosis patients and control healthy.

		TNF-α	IL-6	IL-8
Control		8.51±1.74	16.6±1.88	738.5±98.5
Benign hyperkeratosis	Leukoplakia	12.10±3.96	30.53±6.80	770.74±106.26
	Lichen-planus	13.63±2.04	26.32±4.72	1,071.02±82.61
	Submucous fibrosis	-	-	-
Mild dysplasia	Leukoplakia	14.38±4.27	35.30±7.52	849.58±128.76
	Lichen-planus	18.08±5.27	32.71±8.13	1,074.95±99.17
	Submucous fibrosis	18.41±3.51	34.45±6.72	1,384.10±93.30
Moderate dysplasia	Leukoplakia	18.25±6.50	39.80±10.69	930.61±120.74
	Lichen-planus	18.30±4.94	34.04±8.07	1,071.09±91.65
	Submucous fibrosis	20.37±5.12	35.92±8.32	1,347.18±95.92
Severe dysplasia	Leukoplakia	18.39±3.58	39.61±6.53	919.87±107.65
	Lichen-planus	21.46±5.51	36.06±8.52	1,116.28±118.17
	Submucous fibrosis	24.33±5.16	42.26±9.03	1,437.82±114.69

(NF-κB: nuclear factor-κB, TNF-α: tumor necrosis factor alpha, IL: interleukin)

All data except 'Control' are P<0.05 as compared to control.

Values are presented as mean±standard deviation.